Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-05-21 to 2024-06-12
Current total value of award: $51366.9
Description: 4564730000!XOLAIR 300 MG/2 ML SYRINGE 2ML